SLS

SELLAS Life Sciences Group (SLS)

About SELLAS Life Sciences Group (SLS)

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

Details

Daily high

$8.88

Daily low

$8.34

Price at open

$8.37

52 Week High

$9.51

52 Week Low

$1.39

Market cap

1.5B

Dividend yield

0.00%

Volume

8.1M

Avg. volume

8.7M

P/E ratio

-35.25

SELLAS Life Sciences Group News